The subscription price for the warrants of series TO5 in Wyld Networks AB has been determined to SEK 0.07 and the subscription period starts November 14, 2024

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN,

READ MORE

Africa Oil Announces Third Quarter 2024 Results

VANCOUVER, BC, Nov. 13, 2024 /CNW/ – (AOI–TSX, AOI–Nasdaq-Stockholm) – Africa Oil Corp. (“Africa Oil”, “AOC” or the “Company”) is

READ MORE

MilDef completes a directed share issue of approximately 5.4 million shares, raising proceeds of SEK 500 million

MilDef Group AB (publ) (“MilDef” or the “Company”) has successfully carried out a directed share issue of 5,434,782 shares at

READ MORE

Reporting of transactions made by persons discharging managerial responsibilities

SUGAR LAND, TEXAS, November 13, 2023 /PRNewswire/ – Noble Corporation plc (“Noble”) (CSE: NOBLE, NYSE: NE) today announces that the persons

READ MORE

SmartCraft ASA (SMCRT) – Transactions carried out under the share buy-back program

Please see below information about transactions made under the share buy-back programme for SmartCraft ASA (“SmartCraft”) (Ticker: SMCRT NO). Date

READ MORE

Gentoo Media – Mandatory notification of trade

MJ Foundation Fundacja Rodzinna, a company related to Mateusz Juroszek, Board Member and primary insider of Gentoo Media Inc. (Gentoo) has

READ MORE

Nordea Bank Abp: Repurchase of own shares on 13.11.2024

Nordea Bank AbpStock exchange release – Changes in company’s own shares13.11.2024 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has

READ MORE

Transaction in Own Shares – Fidelity Asian Values Plc

FIDELITY ASIAN VALUES PLC (the ‘Company’)     TRANSACTION IN OWN SHARES     The Board of the Company announces that it has bought into

READ MORE

Transaction in Own Shares – Fidelity China Special Situations Plc

FIDELITY CHINA SPECIAL SITUATIONS PLC (the ‘Company’)     TRANSACTION IN OWN SHARES     The Board of the Company announces that it has repurchased

READ MORE

Stayble Therapeutics’ STA363 receives positive phase 1b results

Stayble Therapeutics AB (“Stayble” or the “Company”) announces positive results from the Company’s clinical phase 1b study in lumbar disc herniation

READ MORE